Most Read Articles
7 days ago
Obesity has a slight and substantial negative impact on the cognitive functioning of healthy individuals and major depressive disorder patients (MDD), respectively, a new study shows.
10 days ago
Increased serum levels of C-X-C motif chemokine (CXCL)-11, CXCL-9, CXCL-10 and interferon (IFN)-γ are associated with clinical manifestations of adult-onset Still’s disease (AOSD), reports a new study.
4 days ago
Myopia is associated with depressive symptoms in Chinese adults, a new population-based study shows.
5 days ago
Chronic obstructive pulmonary disease (COPD) is currently the 10th commonest cause of death in Singapore, with a disease burden of 5.9 percent according to a 2015 population-based survey (EPIC-Asia survey) in Singapore. Pearl Toh spoke with Dr Augustine Tee, chief and senior consultant of the Department of Respiratory and Critical Care Medicine at Changi General Hospital (CGH) in Singapore, on how COPD is often underdetected in the primary care population as symptoms are not specific and diagnosis requires a combination of clinical risk factors, symptoms and spirometry testing.

SSRIs increase risk of glaucoma

2 months ago
A GP who misdiagnosed a patient’s glaucoma - leading to her partial loss of vision - has been suspended by the SMC.

Patients receiving selective serotonin reuptake inhibitors (SSRIs) experience a greater risk of developing glaucoma, a new study reports.

Data from the 2005 Longitudinal Health Insurance Database of the National Health Research Institute of Taiwan were used for the study. Records of 15,865 glaucoma cases were compared to 77,014 age-, sex- insurance premium- and residence-matched controls.

Glaucoma diagnoses included primary angle-closure glaucoma, open-angle glaucoma and glaucoma state, among other specific forms. Those whose glaucoma was caused by corticosteroids, congenital defects, lens disorders or other ocular disorders were excluded. The primary outcome was the incidence of glaucoma.

Participants receiving SSRIs had a greater risk of glaucoma incidence (odds ratio [OR], 1.39; 95 percent CI, 1.29 to 1.50). This relationship remained but was less pronounced after adjusting for possible confounders (aOR, 1.09; 1.00 to 1.18).

Moreover, those who received ≥1 defined daily dose and had received the treatment for more than 365 days showed greater risks of glaucoma (aOR, 1.36; 1.08 to 1.71).

Subgroup analysis showed that only participants without diabetes (aOR, 1.39; 1.27 to 1.52), below the age of 65 (aOR, 1.37; 1.25 to 1.50), without hypercholesterolemia (aOR, 1.35; 1.23 to 1.48) or without hypertension (aOR, 1.46; 1.31 to 1.63) showed increased risks of glaucoma as a result of SSRI treatment.

While future studies are required to determine causality and mechanisms of action, clinicians should make their patients aware of such risks when taking SSRIs and of the signs and symptoms of glaucoma to ensure early detection, researchers said.

Editor's Recommendations
Most Read Articles
7 days ago
Obesity has a slight and substantial negative impact on the cognitive functioning of healthy individuals and major depressive disorder patients (MDD), respectively, a new study shows.
10 days ago
Increased serum levels of C-X-C motif chemokine (CXCL)-11, CXCL-9, CXCL-10 and interferon (IFN)-γ are associated with clinical manifestations of adult-onset Still’s disease (AOSD), reports a new study.
4 days ago
Myopia is associated with depressive symptoms in Chinese adults, a new population-based study shows.
5 days ago
Chronic obstructive pulmonary disease (COPD) is currently the 10th commonest cause of death in Singapore, with a disease burden of 5.9 percent according to a 2015 population-based survey (EPIC-Asia survey) in Singapore. Pearl Toh spoke with Dr Augustine Tee, chief and senior consultant of the Department of Respiratory and Critical Care Medicine at Changi General Hospital (CGH) in Singapore, on how COPD is often underdetected in the primary care population as symptoms are not specific and diagnosis requires a combination of clinical risk factors, symptoms and spirometry testing.